Transfusion strategies for traumatic coagulopathy

Blood Reviews

Volumn 26, Issue 5, 2012, Pages 223-232

  Curry, Nicola S ^a   Davenport, Ross A ^b   Hunt, Beverley J ^c   Stanworth, Simon J ^a  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Haemostatic resuscitation; Major haemorrhage; Major haemorrhage protocols; Thromboelastometry; Transfusion; Traumatic coagulopathy

Indexed keywords

ACTIVATED PROTEIN C; FIBRIN; FIBRINOGEN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN; THROMBOPLASTIN; TRANEXAMIC ACID;

ARTICLE; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; COLLOID; CRYSTALLOID; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; FIBRINOLYSIS; FLUID RESUSCITATION; FLUID THERAPY; HEMATOLOGICAL PARAMETERS; HEMOSTASIS; HUMAN; PARTIAL THROMBOPLASTIN TIME; PATHOGENESIS; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK ASSESSMENT; RISK FACTOR; THROMBOCYTE ACTIVATION; THROMBOELASTOGRAPHY; TRAUMATIC COAGULOPATHY; TREATMENT INDICATION; VISCOELASTIC TEST;

BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; BLOOD TRANSFUSION; HUMANS; TREATMENT OUTCOME; WOUNDS AND INJURIES;

EID: 84865161488     PISSN: 0268960X     EISSN: 15321681     Source Type: Journal    
DOI: 10.1016/j.blre.2012.06.004     Document Type: Article

References (129)

1. WHO World Health Organisation. Global Health Indicators 2011, http://www.who.int/whosis/whostat/EN_WHS2011_Part2.pdf.
2. Sauaia A., Moore F.A., Moore E.E., Moser K.S., Brennan R., Read R.A., et al. Epidemiology of trauma: a reassessment. J Trauma 1995, 38:185-193.
3. Spinella P.C., Holcomb J.B. Resuscitation and transfusion principles for traumatic hemorrhagic shock. Blood Rev 2009, 23:231-240.
4. Borgman M.A., Spinella P.C., Perkins J.G., Grathwohl K.W., Repine T., Beekley A.C., et al. The ratio of blood products transfused affects the mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007, 63:805-813.
5. Rossaint R., Bouillon B., Cerny V., Coats T.J., Duranteau J., Fernández-Mondéjar E., et al. Management of bleeding following major trauma : an updated European guideline. Crit Care 2010, 14:R52.
6. Jansen J.O., Thomas R., Loudon M.A., Brooks A. Damage control resuscitation for patients with major trauma. BMJ 2009, 338:1436-1440.
7. Bolliger D., Szlam F., Molinaro R.J., Rahe-Meyer N., Levy J.H., Tanaka K.A. Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model. Br J Anaesth 2009, 102:793-799.
8. Maegele M., Lefering R., Yucel N., Tjardes T., Rixen D., Paffrath T., et al. Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients. Injury 2007, 38:298-304.
9. Hunt B.J., Jurd K.M. Endothelial cell activation. BMJ 1998, 316:1328-1329.
10. Johansson P.I., Sorensen A.M., Perner A., Welling K.L., Wanscher M., Larsen C.F., et al. Disseminated intravascular coagulation or acute coagulopathy of trauma shock early after trauma? A prospective observational study. Crit Care 2011, 15:R272.
11. Martini W.Z., Chinkes D.L., Pusateri A.E., Holcomb J.B., Yu Y.M., Zhang X.J., et al. Acute changes in fibrinogen metabolism and coagulation after hemorrhage in pigs. Am J Physiol Endocrinol Metab 2005, 289:E930-E934.
12. Wolberg A.S., Campbell R.A. Thrombin generation, fibrin clot formation and hemostasis. Transfus Apher Sci 2008, 38:15-23.
13. Martini W.Z., Holcomb J.B. Acidosis and coagulopathy: the differential effects on fibrinogen synthesis and breakdown in pigs. Ann Surg 2007, 246:851-853.
14. Valeri C.R., Khuri S., Ragno G. Nonsurgical bleeding diathesis in anemic thrombocytopenic patients: role of temperature, red blood cells, platelets, and plasma-clotting proteins. Transfusion 2007, 47:S206-S248.
15. Eugster M., Reinhart W.H. The influence of the haematocrit on primary haemostasis in vitro. Thromb Haemost 2005, 94:1213-1218.
16. Brohi K., Cohen M.J., Ganter M.T., Matthay M.A., Mackersie R.C., Pittet J.-F. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway?. Ann Surg 2007, 245:812-818.
17. Brohi K., Singh J., Heron M., Coats T. Acute traumatic coagulopathy. J Trauma 2003, 54:1127-1130.
18. Macleod J.B., Lynn M., McKenney M.G., Cohn S.M., Murtha M. Early coagulopathy predicts mortality in trauma. J Trauma 2003, 55:39-44.
19. Brohi K., Cohen M.J., Ganter M.T., Schultz M.J., Levi M., Mackersie R.C., et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma 2008, 64:1211-1217.
20. Frith D., Goslings J.C., Gaarder C., Maegele M., Cohen M.J., Allard S., et al. Definition and drivers of acute traumatic coagulopathy: clinical and experimental investigations. J Thromb Haemost 2010, 8:1919-1925.
21. Davenport R., Manson J., De'Ath H., Platton S., Coates A., Allard S., et al. Functional definition and characterization of acute traumatic coagulopathy. Crit Care Med 2011, 39:2652-2658.
22. CRASH-2 trial collaborators Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial. Lancet 2010, 376:23-32.
23. Dunbar N.M., Chandler W.L. Thrombin generation in trauma patients. Transfusion 2009, 49:2652-2660.
24. Floccard B., Rugeri L., Faure A., Denis M.S., Boyle E.M., Peguet O., et al. Early coagulopathy in trauma patients: an on-scene and hospital admission study. Injury 2012, 43:26-32.
25. Jansen J.O., Scarpelini S., Pinto R., Tien H.C., Callum J., Rizoli S.B. Hypoperfusion in severely injured trauma patients is associated with reduced coagulation factor activity. J Trauma 2011, 71:S435-S440.
26. Shaz B.H., Winkler A.M., James A.B., Hillyer C.D., MacLeod J.B. Pathophysiology of early trauma-induced coagulopathy: Emerging evidence for hemodilution and coagulation factor depletion. J Trauma 2011, 70:1401-1407.
27. Chandler W. Procoagulant activity in trauma patients. Am J Clin Pathol 2010, 134:90-96.
28. Hayakawa M., Sawamura A., Gando S., Kubota N., Uegaki S., Shimojima H., et al. Disseminated intravascular coagulation at an early phase of trauma is associated with consumption coagulopathy and excessive fibrinolysis both by plasmin and neutrophil elastase. Surgery 2011, 149:221-230.
29. Yuan S., Ferrell C., Chandler W.L. Comparing the prothrombin time INR versus the APTT to evaluate the coagulopathy of acute trauma. Thromb Res 2007, 120:29-37.
30. Omar M.N., Mann K.G. Inactivation of factor Va by plasmin. J Biol Chem 1987, 262:9750-9755.
31. Davenport R., Rourke C., Manson J., De'Ath H., Platton S., Coates A., et al. Activated protein C is a principle mediator of acute traumatic coagulopathy. Abstracts of the XXIII Congress of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2011, 9(S2):51-52.
32. Cohen M.J., Call M., Nelson M., Calfee C.S., Esmon C.T., Brohi K., et al. Critical role of activated Protein C in early coagulopathy and later organ failure, infection and death in trauma patients. Ann Surg 2012, 255:379-385.
33. Faller D.V. Endothelial cell responses to hypoxic stress. Clin Exp Pharmacol Physiol 1999, 26:74-84.
34. Niles S.E., McLaughlin D.F., Perkins J.G., Wade C.E., Li Y., Spinella P.C., et al. Increased mortality associated with the early coagulopathy of trauma in combat casualties. J Trauma 2008, 64:1459-1465.
35. Pinksy D.J., Yan S.F., Lawson C., Naka Y., Chen J.X., Connolly E.S., et al. Hypoxia and modification of the endothelium: implications for regulation of vascular homeostatic properties. Semin Cell Biol 1995, 6:283-294.
36. Kashuk J.L., Moore E.E., Sawyer M., Wohlauer M., Pezold M., Barnett C., et al. Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma. Ann Surg 2010, 252:434-444.
37. Levrat A., Gros A., Rugeri L., Floccard B., Negrier C., David J.-S. Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients. Br J Anaesth 2008, 100:792-797.
38. Sawamura A., Hayakawa M., Gando S., Kubota N., Sugano M., Wada T., et al. Disseminated intravascular coagulation with a fibrinolytic phenotype at an early phase of trauma predicts mortality. Thromb Res 2009, 124:608-613.
39. Schöchl H., Frietsch T., Pavelka M., Jámbor C. Hyperfibrinolysis after major trauma: differential diagnosis of lysis patterns and prognostic value of thrombelastometry. J Trauma 2009, 67:125-131.
40. Schöchl H., Nieaber U., Hofer G., Voelckel W., Jambor C., Scharbert G., et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010, 14:R55.
41. CRASH-2 collaborators The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011, 377:1096-1101.
42. Kushimoto S., Gando S., Saitoh D., Ogura H., Mayumi T., Koseki K., et al. Clinical course and outcome of disseminated intravascular coagulation diagnosed by Japanese Association for Acute Medicine criteria. Comparison between sepsis and trauma. Thromb Hemost 2008, 100:1099-1105.
43. Chen J.P., Rowe D.W., Enderson B.L. Contrasting post-traumatic serial changes for D-dimer and PAI-1 in critically injured patients. Thromb Res 1998, 94:175-185.
44. Rugeri L., Levrat A., David J.S., Delecroix E., Floccard B., Gros A., et al. Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography. J Hemost Thromb 2007, 5:289-295.
45. Ten V.S., Pinsky D.J. Endothelial response to hypoxia: physiologic adaptation and pathologic dysfunction. Curr Opin Crit Care 2002, 8:242-250.
46. Gando S., Sawamura A., Hayakawa M. Trauma, shock and disseminated intravascular coagulation: lessons from the classical literature. Ann Surg 2011, 254:10-19.
47. Rizoli S., Nascimento B., Key N., Tien H.C., Muraca S., Pinto R., et al. Disseminated intravascular coagulopathy in the first 24hours after trauma: the association between ISTH score and anatomopathologic evidence. J Trauma 2011, 71:S441-S447.
48. Reed M.J., Lone N., Walsh T.S. Resuscitation of the trauma patient: tell me a trigger for early haemostatic resuscitation please!. Crit Care 2011, 15:126.
49. Ruchholtz S., Pehle B., Lewan U., Lefering R., Müller N., Oberbeck R., et al. The emergency room transfusion score (ETS): prediction of blood transfusion requirement in initial resuscitation after severe trauma. Transfus Med 2006, 16:49-56.
50. Yücel N., Lefering R., Maegele M., Vorweg M., Tjardes T., Ruchholtz S., et al. Trauma Associated Severe Hemorrhage (TASH)-Score: probability of mass transfusion as surrogate for life threatening hemorrhage after multiple trauma. J Trauma 2006, 60:1228-1237.
51. Maegele M., Lefering R., Wafaisade A., Theodorou P., Wutzler S., Fischer P., et al. Revalidation and update of the TASH-Score: a scoring system to predict the probability for massive transfusion as a surrogate for life-threatening haemorrhage after severe injury. Vox Sang 2011, 100:231-238.
52. Schreiber M.A., Perkins J., Kiraly L., Underwood S., Wade C., Holcomb J.B. Early predictors of massive transfusion in combat casualties. J Am Coll Surg 2007, 205:541-545.
53. McLaughlin D.F., Niles S.E., Salinas J., Perkins J.G., Cox E.D., Wade C.E., et al. A predictive model for massive transfusion in combat casualty patients. J Trauma 2008, 64(S2):S57-S63.
54. Cancio L.C., Wade C.E., West S.A., Holcomb J.B. Prediction of mortality and of the need for massive transfusion in casualties arriving at combat support hospitals in Iraq. J Trauma 2008, 64:S51-S56.
55. Nunez T.C., Voskresensky I.V., Dossett L.A., Shinall R., Dutton W.D., Cotton B.A. Early prediction of massive transfusion in trauma: simple as ABC (assessment of blood consumption)?. J Trauma 2009, 66:346-352.
56. Stanworth S.J., Morris T.P., Gaarder C., Goslings J.C., Maegele M., Cohen M.J., et al. Reappraising the concept of massive transfusion in trauma. Crit Care 2010, 14:R239.
57. Cosgriff N., Moore E., Sauaia A., Kenny-Moynihan M., Burch J.M., Galloway B. Predicting life-threatening coagulopathy in the massively transfused trauma patients: hypothermia and acidosis revisited. J Trauma 1997, 42:857-862.
58. Dzik W.H. Predicting hemorrhage using preoperative coagulation screening assays. Curr Hematol Rep 2004, 3:324-330.
59. Ak A., Isbir C.S., Tetik S., Atalan N., Tekeli A., Alijodi M., et al. Thromboelastography-based transfusion algorithm reduces blood product use after elective CABG: a prospective randomized study. J Card Surg 2009, 24:404-410.
60. Wang S.C., Shieh J.F., Chang K.Y., Chu Y.C., Liu C.S., Loong C.C., et al. Thromboelastography-guided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation: randomized clinical trial. Transplant Proc 2010, 42:2590-2593.
61. Kaufmann C.R., Dwyer K., Crews J.D., Dols S.J., Trask A.L. Usefulness of thromboelastography in assessment of trauma patient coagulation. J Trauma 1997, 42:716-722.
62. Plotkin A.J., Wade C.E., Jenkins D.H., Smith K.A., Noe J.C., Park M.S., et al. A reduction in clot formation rate and strength assessed by thrombelastography is indicative of transfusion requirements in patients with penetrating injuries. J Trauma 2008, 64:S64-S68.
63. Johansson P.I., Bochsen L., Stensballe J., Secher N.H. Transfusion packages for massively bleeding patients: the effect on clot formation and stability as evaluated by Thromboelastograph (TEG). Transfus Apher Sci 2008, 39:3-8.
64. Carroll R.C., Craft R.M., Langdon R.J., Clanton C.R., Snider C.C., Wellons D.D., et al. Early evaluation of acute traumatic coagulopathy by thromboelastography. Transl Res 2009, 154:34-39.
65. Tauber H., Innerhofer P., Breitkopf R., Westermann I., Beer R., El Attal R., et al. Prevalence and impact of abnormal ROTEM assays in severe blunt trauma: results of the 'Diagnosis and Treatment of Trauma-Induced Coagulopathy (DIA-TRE-TIC) study'. Br J Anaesth 2011, 107:378-387.
66. Johansson P.I., Stissing T., Bochsen L., Ostrowski S.R. Thrombelastography and thromboelastometry in assessing coagulopathy in trauma. Scand J Trauma Resusc Emerg Med 2009, 17:45.
67. Ostrowski S.R., Sørensen A.M., Larsen C.F., Johansson P.I. Thrombelastography and biomarker profiles in acute coagulopathy of trauma: a prospective study. Scand J Trauma Resusc Emerg Med 2011, 19:64.
68. Hunt B.J., Segal H. Hyperfibrinolysis. J Clin Pathol 1996, 49:958.
69. Fenger-Eriksen C., Tønnesen E., Ingerslev J., Sørensen B. Mechanisms of hydroxyethyl starch-induced dilutional coagulopathy. J Thromb Haemost 2009, 7:1099-1105.
70. Fenger-Eriksen C., Moore G.W., Rangarajan S., Ingerslev J., Sørensen B. Fibrinogen estimates are influenced by methods of measurement and hemodilution with colloid plasma expanders. Transfusion 2010, 50:2571-2576.
71. Eastridge B.J., Malone D., Holcomb J.B. Early predictors of transfusion and mortality after injury: a review of the data-based literature. J Trauma 2006, 60:S20-S25.
72. Duschesne J.C., Hunt J.P., Wahl G., Marr A.B., Wang Y.-Z., Weintraub S.E., et al. Review of current blood transfusions strategies in a mature level 1 trauma center: were we wrong for the last 60 years?. J Trauma 2008, 65:272-276.
73. Maegele M., Lefering R., Paffrath T., Tjardes T., Simanski C., Bouillon B., et al. Red-blood-cell to plasma ratios transfused during massive transfusion are associated with mortality in severe multiple injury: a retrospective analysis from the Trauma Registry of the Deutsche Gesellschaft für Unfallchirurgie. Vox Sang 2008, 95:112-119.
74. Holcomb J.B., Wade C.E., Michalek J.E., Chisholm G.B., Zarzabal L.A., Schreiber M.A., et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 2008, 248:447-458.
75. Scalea T.M., Bochicchio K.M., Lumpkins K., Hess J.R., Dutton R., Pyle A., et al. Early aggressive use of fresh frozen plasma does not improve outcome in critically injured trauma patients. Ann Surg 2008, 248:578-584.
76. Kashuk J.L., Moore E.E., Johnson J.L., Haenel J., Wilson M., Moore J.B., et al. Postinjury life threatening coagulopathy: Is 1:1 fresh frozen plasma: packed red blood cells the answer?. J Trauma 2008, 65:261-270.
77. Sperry J.L., Ochoa J.B., Gunn S.R., Alarcon L.H., Minei J.P., Cuschieri J., et al. An FFP:PRBC transfusion ratio >/=1:1.5 is associated with a lower risk of mortality after massive transfusion. J Trauma 2008, 65:986-993.
78. Snyder C.W., Weinberg J.A., McGwin G., Melton S.M., George R.L., Reiff D.A., et al. The relationship of blood product ratio to mortality: survival benefit or survival bias?. J Trauma 2009, 66:358-364.
79. Gunter O.L., Au B.K., Isbell J.M., Mowery N.T., Young P.P., Cotton B.A. Optimizing outcomes in damage control resuscitation: identifying blood product ratios associated with improved survival. J Trauma 2008, 65:527-534.
80. Johansson P.I., Stensballe J. Effect of haemostatic control resuscitation on mortality in massively bleeding patients: a before and after study. Vox Sang 2009, 96:111-118.
81. Teixiera P.G.R., Inaba K., Shulman I., Salim A., Demetriades D., Brown C., et al. Impact of plasma transfusion in massively transfused trauma patients. J Trauma 2009, 66:693-697.
82. Riskin D.J., Tsai T.C., Riskin L., Hernandez-Boussard T., Purtill M., Maggio P.M., et al. Massive transfusion protocols: the role of aggressive resuscitation versus product ratio in mortality reduction. J Am Coll Surg 2009, 209:198-205.
83. Zink K.A., Sambasivan C.N., Holcomb J.B., Chisholm G., Schreiber M.A. A high ratio of plasma and platelets to packed red blood cells in the first 6hours of massive transfusion improves outcomes in a large multicentre study. Am J Surg 2009, 197:565-570.
84. Davenport R., Curry N., Manson J., De'Ath, H., Coates A., Rourke C., et al. Hemostatic effects of fresh frozen plasma may be maximal at red cell ratios of 1:2. J Trauma 2011, 70:90-96.
85. Murad M.H., Stubbs J.R., Gandhi M.J., Wang A.T., Paul A., Erwin P.J., et al. The effect of plasma transfusion on morbidity and mortality: a systematic review and meta-analysis. Transfusion 2010, 50:1370-1383.
86. Zehtabchi S., Nishijima D.K. Impact of transfusion of fresh-frozen plasma and packed red blood cells in a 1:1 ratio on survival of emergency department patients with severe trauma. Acad Emerg Med 2009, 16:371-378.
87. Phan H.H., Wisner D.H. Should we increase the ratio of plasma/platelets to red blood cells in massive transfusion: what is the evidence?. Vox Sang 2010, 98:395-402.
88. Johansson P.I., Stensballe J. Hemostatic resuscitation for massive bleeding: the paradigm of plasma and platelets - a review of the current literature. Transfusion 2010, 50:701-710.
89. Stansbury L.G., Dutton R.P., Stein D.M., Bochicchio G.V., Scalea T.M., Hess J.R. Controversy in trauma resuscitation: do ratios of plasma to red blood cells matter?. Transfus Med Rev 2009, 23:255-265.
90. de Biasi A.R., Stansbury L.G., Dutton R.P., Stein D.M., Scalea T.M., Hess J.R. Blood product use in trauma resuscitation: plasma deficit versus plasma ratio as predictors of mortality in trauma. Transfusion 2011, 51:1925-1932.
91. Magnotti L.J., Zarzaur B.L., Fischer P.E., Williams R.F., Myers A.L., Bradburn E.H., et al. Improved survival after haemostatic resuscitation: does the emperor have no clothes?. J Trauma 2011, 70:97-102.
92. Fergusson D.A., Hébert P.C., Mazer C.D., Fremes S., MacAdams C., Murkin J.M., et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. NEJM 2008, 358:2319-2331.
93. Rajasekhar A., Gowing R., Zarychanski R., Arnold D.M., Lim W., Crowther M.A., et al. Survival of trauma patients after massive red blood cell transfusion using a high or low red cell to plasma transfusion ratio. Crit Care Med 2011, 39:1507-1513.
94. PROPPR: Prospective Randomised Optimum Platelet and Plasma Ratios Trial http://www.uth.tmc.edu/cetir/PROPPR/index.html.
95. Shaz B.H., Dente C.J., Nicholas J., MacLeod J.B., Young A.N., Easley K., et al. Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients. Transfusion 2010, 50:493-500.
96. Inaba K., Lustenberger T., Rhee P., Holcomb J.B., Blackbourne L.H., Shulman I., et al. The impact of platelet transfusion in massively transfused trauma patients. J Am Coll Surg 2010, 211:573-579.
97. Solomon C., Traintinger S., Ziegler B., Hanke A., Rahe-Meyer N., Voelckel W., et al. Platelet function following trauma. a multiple electrode aggregometry study. Thromb Haemost 2011, 106:322-330.
98. Repine T.B., Perkins J.G., Kauvar D.S., Blackborne L. The use of fresh whole blood in massive transfusion. J Trauma 2006, 60:S59-S69.
99. Spinella P.C. Warm fresh whole blood transfusion for severe hemorrhage: U.S. military and potential civilian applications. Crit Care Med 2008, 36:S340-S345.
100. Mohr R., Martinowitz U., Lavee J., Amroch D., Ramot B., Goor D.A. The hemostatic effect of transfusing fresh whole blood versus platelet concentrates after cardiac operations. J Thorac Cardiovasc Surg 1988, 96:530-534.
101. Laine E., Steadman R., Calhoun L., Blackall D., Levin P., Braunfeld M., et al. Comparison of RBCs and FFP with whole blood during liver transplant surgery. Transfusion 2003, 43:322-327.
102. NCT01227005. Early whole blood in patients requiring transfusion after major trauma. Houston: The University of Texas Health Science Center; 2012. []. http://www.clinicaltrials.gov.
103. Charles A., Shaikh A., Walters M., Huehl S., Pomerantz R. Blood transfusion is an independent predictor of mortality after blunt trauma. Am Surg 2007, 73:1-5.
104. Malone D.L., Dunne J., Tracy J.K., Putnam T., Scalea T.M., Napolitano L.M. Blood transfusion, independent of shock severity is associated with worse outcome in trauma. J Trauma 2003, 54:898-907.
105. Spinella P.C., Perkins J.G., Grathwohl K.W., Beekley A.C., Niles S.E., McLaughlin D.F., et al. Effect of plasma and red blood cell transfusions on survival in patients with combat related traumatic injuries. J Trauma 2008, 64:S69-S78.
106. Hill G.E., Frawley W.H., Griffith K.E., Foretner J.E., Minei J.P. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma 2003, 54:908-914.
107. Lelubre C., Piagnerelli M., Vincent J.L. Association between duration of storage of transfused red blood cells and morbidity and mortality in adult patients: Myth or reality?. Transfusion 2009, 49:1384-1394.
108. Curry N., Stanworth S., Hopewell S., Dorée C., Brohi K., Hyde C. Trauma induced coagulopathy - a review of the systematic reviews: is there sufficient evidence to guide clinical transfusion practice?. Transfus Med Rev 2011, 25:217-231.
109. Bochicchio G.V., Napolitano L., Joshi M., Bochicchio K., Meyer W., Scalea T.M. Outcome analysis of blood product transfusion in trauma patients: a prospective, risk-adjusted study. World J Surg 2008, 32:2185-2189.
110. Inaba K., Branco B.C., Rhee P., Holcomb J.B., Blackbourne L.H., Shulman I., et al. Impact of ABO-identical vs ABO-compatible nonidentical plasma transfusion in trauma patients. Arch Surg 2010, 145:899-906.
111. Watson G.A., Sperry J.L., Rosengart M.R., Minei J.P., Harbrecht B.G., Moore E.E., et al. Fresh frozen plasma is independently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome. J Trauma 2009, 67:221-230.
112. Cotton B.A., Au B.K., Nunez T.C., Gunter O.L., Robertson A.M., Young P.P. Predefined massive transfusion protocols are associated with a reduction in organ failure and postinjury complications. J Trauma 2009, 66:41-49.
113. Hiippala S. Replacement of massive blood loss. Vox Sang 1998, 74(S2):399-407.
114. Dente C.J., Shaz B.H., Nicholas J.M., Harris R.S., Wyrzykowski A.D., Patel S., et al. Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian level 1 trauma centre. J Trauma 2009, 66:1616-1624.
115. Stinger H.K., Spinella P.C., Perkins J.G., Grathwohl K.W., Salinas J., Martini W.Z., et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma 2008, 64:S79-S85.
116. Dickneite G., Pragst I., Joch C., Bergman G.E. Animal model and clinical evidence indicating low thrombogenic potential of fibrinogen concentrate (Haemocomplettan P). Blood Coagul Fibrinolysis 2009, 20:535-540.
117. Warmuth M., Mad P., Wild C. Systematic review of the efficacy and safety of fibrinogen concentrate substitution in adults. Acta Anaesthesiol Scand Dec 12 2011, [Epub ahead of print].
118. Schöchl H., Nienaber U., Maegele M., Hochleitner G., Primavesi G., Steitz B., et al. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care 2011, 15:R83.
119. Nienaber U., Innerhofer P., Westermann I., Schöchl H., Attal R., Breitkopf R., et al. The impact of fresh frozen plasma vs. coagulation factor concentrates on morbidity and mortality in trauma-associated haemorrhage and massive transfusion. Injury 2011, 42:697-701.
120. Grottke O., Braunschweig T., Spronk H.M., Esch S., Rieg A.D., van Oerle R., et al. Increasing concentrations of prothrombin complex concentrate induce DIC in a pig model of coagulopathy with blunt liver injury. Blood 2011, 118:1943-1951.
121. Martinowitz U., Kenet G., Segal E., Luboshitz J., Lubetsky A., Ingerslev J., et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 2001, 51:431-439.
122. Kenet G., Walden R., Eldad A., Martinowitz U. Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 1999, 354:1879.
123. Dutton R.P., McCunn M., Hyder M., D'Angelo M., O'Connor J., Hess J.R., et al. Factor VIIa for correction of traumatic coagulopathy. J Trauma 2004, 57:709-719.
124. Boffard K.D., Riou B., Warren B., Choong P.I., Rizoli S., Rossaint R., et al. Recombinant Factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 2005, 59:8-18.
125. Hauser C.J., Boffard K., Dutton R., Bernard G.R., Croce M.A., Holcomb J.B., et al. Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage. J Trauma 2010, 69:489-500.
126. Simpson E., Lin Y., Stanworth S., Birchall J., Doree C., Hyde C. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev 2012, 14(3):CD005011.
127. Levi M., Levy J.H., Anderson H.F., Truloff D. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med 2010, 363:1791-1800.
128. Young P.P., Cotton B.A., Goodnough L.T. Massive transfusion protocols for patients with substantial haemorrhage. Transfus Med Rev 2011, 25:293-303.
129. Dzik W.H., Blajchman M.A., Fergusson D., Hameed M., Henry B., Kirkpatrick A.W., et al. Clinical review: Canadian National Advisory Committee on Blood and Blood Products - Massive Transfusion Consensus Conference 2011: report of the panel. Crit Care 2011, 15:242.